Saad Usmani

MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center, US

Specializes in [Hematology/Oncology]

• Professor and Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center, New York
• Led clinical development of several novel therapies including anti-CD38 monoclonal antibodies, bispecific antibodies and CART cell therapies to regulatory approvals
• More than 380 peer-reviewed research manuscripts (NEJM, Lancet, Nature Medicine, JCO, Cancer Cell, Blood, Leukemia, etc.)

tosprivacy